Advertisement
Advertisement
April 29, 2021
Perflow Medical’s Stream17 Dynamic Neurothrombectomy Net Introduced in Europe
April 29, 2021—Perflow Medical announced the first successful clinical use of the Stream17 dynamic neurothrombectomy net in the treatment of hemorrhagic and ischemic stroke patients. The first clinical procedures were successfully completed by Professor Karlis Kupcs, MD, who is head of Radiology at the Pauls Stradins Clinical University Hospital in Riga, Latvia.
According to Perflow Medical, the low-profile Stream17 device, which is built on the company’s Cerebral Net technology, is designed for tortuous anatomy. Stream17 adds to Perflow Medical’s product portfolio that also includes the recently commercialized Cascade17 dynamic nonocclusive remodeling net for coil embolization of intracranial aneurysms.
Perflow’s stroke products are used to perform mechanical thrombectomy from proximal large vessel occlusions up to the distal blood clots in the distal M2/M3 segments. Both the Cascade Net and Stream Net product families are commercially available across Europe for the treatment of intracranial aneurysms and acute ischemic stroke, respectively. Perflow products are not yet cleared for clinical use within the United States, advised the company.
“We recently brought the Stream family of products into our institution and I have been very pleased with the additional physician control and positive outcomes when using this next generation stentriever in my practice,” commented Prof. Kupcs in Perflow Medical’s press release. “With the Stream17, I appreciate the ability to navigate through a small 0.017-inch microcatheter to effectively remove thrombus in more distal vessels. Moreover, the device was easy to use and resulted in efficient, full recanalization of the vessel.”
In addition, Paul Bhogal, MD, interventional radiologist at Barts Health NHS Trust in London, United Kingdom, noted, “Our center is one of the most active in the country for stroke with a comprehensive range of treatments and consistently excellent clinical results. As part of that achievement, we believe in the value of adopting promising new tools, such as Perflow’s dynamic-control net devices, and have integrated them into our toolbox. I’m especially excited about the Stream17, which enables access to previously unreachable blockages.”
Advertisement
Advertisement